A major global health issue is the existence of chronic wounds. Diabetic ulcers, arterial and venous ulcers, and pressure ulcers are some of the most common types of chronic wounds. The burden of chronic wounds continues to rise due to the current epidemic of obesity and diabetes, and the increase in elderly adults in the population who are more vulnerable to chronic wounds than younger individuals. Microbial infection is the most common challenge to wound healing, and some opportunistic pathogens are able to evade various pharmaceutical and personal care products. Chronic wounds are normally colonized by a large collection of pathogenic bacteria or fungi that are more likely to form biofilms, and directly contribute to delayed wound healing. Appropriate diagnosis and treatment of Multi-drug resistant (MDR) organisms in chronic wounds is essential to promote wound healing and prevent further complications.
Traditional methods for treatment and diagnosis have shown to be of limited effectiveness. Therefore, there is a need for the development of diagnostic and therapeutic innovations in chronic wound care. This Research Topic aims to provide insight in the wound healing process and the deficiencies encountered in chronic wounds, which provides a basis for the development of innovations in chronic wound care. Furthermore, promising diagnostic and therapeutic innovations will be highlighted, and we also hope to find out the source of some special infectious microorganisms, such as Burkholderia cepacia, which comes from different types of pharmaceutical care products.
This Research Topic welcomes Original Research, Reviews, and other article types focusing on, but not limited to, the following topics:
• Distribution and antimicrobial susceptibility pattern of pathogenic bacteria in patients or animals with chronic wounds;
• New technology/new method for detection and diagnosis of multi-drug-resistant bacteria or fungi;
• New drugs or other materials for the treatment of multiple drug-resistant bacteria or fungi in chronic wounds;
• New technologies/new methods for early warning of chronic wound infections;
• Tracing analysis of infectious microorganisms;
• Review of current research on multiple drug-resistant bacteria or fungi in chronic wounds.
A major global health issue is the existence of chronic wounds. Diabetic ulcers, arterial and venous ulcers, and pressure ulcers are some of the most common types of chronic wounds. The burden of chronic wounds continues to rise due to the current epidemic of obesity and diabetes, and the increase in elderly adults in the population who are more vulnerable to chronic wounds than younger individuals. Microbial infection is the most common challenge to wound healing, and some opportunistic pathogens are able to evade various pharmaceutical and personal care products. Chronic wounds are normally colonized by a large collection of pathogenic bacteria or fungi that are more likely to form biofilms, and directly contribute to delayed wound healing. Appropriate diagnosis and treatment of Multi-drug resistant (MDR) organisms in chronic wounds is essential to promote wound healing and prevent further complications.
Traditional methods for treatment and diagnosis have shown to be of limited effectiveness. Therefore, there is a need for the development of diagnostic and therapeutic innovations in chronic wound care. This Research Topic aims to provide insight in the wound healing process and the deficiencies encountered in chronic wounds, which provides a basis for the development of innovations in chronic wound care. Furthermore, promising diagnostic and therapeutic innovations will be highlighted, and we also hope to find out the source of some special infectious microorganisms, such as Burkholderia cepacia, which comes from different types of pharmaceutical care products.
This Research Topic welcomes Original Research, Reviews, and other article types focusing on, but not limited to, the following topics:
• Distribution and antimicrobial susceptibility pattern of pathogenic bacteria in patients or animals with chronic wounds;
• New technology/new method for detection and diagnosis of multi-drug-resistant bacteria or fungi;
• New drugs or other materials for the treatment of multiple drug-resistant bacteria or fungi in chronic wounds;
• New technologies/new methods for early warning of chronic wound infections;
• Tracing analysis of infectious microorganisms;
• Review of current research on multiple drug-resistant bacteria or fungi in chronic wounds.
